Health ❯ Healthcare ❯ Patient Outcomes

Treatment Efficacy

Side Effects Response Rates Ear Discharge Resolution Cancer Remission Durability of Response Hair Regrowth Adverse Effects Steroid Use Reduction Overall Survival Long-term Monitoring Satisfaction with Hair Coverage Progression-Free Survival Relapse Prevention Medication Timing HbA1c Levels Muscle Pain Reduction

Swedish Study Ties Lower Ipilimumab Dose to Longer Survival and Less Toxicity in Advanced Melanoma

The JNCI publication reports retrospective results that now warrant prospective trials plus regulatory review.

Veradermics Advances Long-Acting Oral Minoxidil Into Phase 3 U.S. Trials

FDA Approves Lurbinectedin Plus Atezolizumab for First-Line Maintenance in Extensive-Stage SCLC